YAP1 and cancer: Integrative single-cell multi-omics approaches, coupled with chromatin immunoprecipitation sequencing (ChIP-seq) and assay for transposase-accessible chromatin using sequencing (ATAC-seq), will be essential for delineating YAP-target networks in diverse tumors (Yu et al., 2023), offering mechanistic insights and new opportunities for targeting inflammation in cancer.